Value Line Investment published report below: - Estimated 2021/2: 15% - Dividend 2021/2: 1%
A good opportunity to buy at the price close to the support region. Take profit 1 - $92 Take profit 2 - $103 Many new products will be launching and shared in September with a chance of having a higher price.
Due to people's concern with possible variants, it is likely that there is an appreciation of the biotech market. Take profit at $362 - 50%
Disruption of resistance is likely consolidation of an uptrend.
Due to people's concern with possible variants, it is likely that there is an appreciation of the biotech market. The take profit can be possible at $179
The price of 69 dol was the historic resistance region at Jan-2018, then there was a break of resistance and the price reached a new peak at 86 dol forming a new high region. We currently expect the price to recover in that same region of 86 dol.
Probable retraction at the 0.2 region Fibo.
Still, with Covid-19 cases fading and gradually declining, the possibility of a recovery is real. So if you really want to play, AYRO could be your ticket.
Evofem's flagship product is Phexxi which is approved by the food and drug administration and is the first and only hormone-free prescription contraceptive "privacy"gel. As well, the company has several products in development, including EVO100, which is another privacy gel designed to reduce chlamydia and gonorrhea in women.
Its possible that Covid could cause shifts in social behavior that might favor more introverted or insular activities such as home gym equipment. But this is speculation at best so bet on NLS extremely carefully.
According to a survey that the company conducted with interbrand, data breaches could potentially risk up to 223 billion in value of the worlds top 100 brands. Further, that risk has presumabley only increased because of the Covid-19 pandemic forcing employees of major corporations to operate remotely.
Reason: For a little over one year, the pandemic forced people to avoid or cancel vacations and spend money on the products and services they wanted. Instead they had to stock up on food, guns, and toilet paper. Therefore, the current price point of CNK stock is attractive.
ETH CASH AND RECOVERY TARGET
Consolidated canal and price is at 50% causing indecision. My option is to wait for the price to touch the canal support region.
Price analysis is in a support and resistance region. Take profit at region $11.3
Buying suggestion as it is in the support region. My ideal take profit $19.
Ascending demand with little commodity supply and investment in extraction project in the past. Target at double price.
Price recovery due to the end of covid 19, as well as the reduction of reserves and production decrease. Factors: - Environmental; - Production Reduction; - New Norms for Extraction;